Pictured: Woman grasping her stomach in pain/iStock, Doucefleur The use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, such as Novo Nordisks Ozempic and Wegovy, is associated with the risk of gastrointestinal adverse events, according to a study published Thursday in the medical journal JAMA
But what if the majority of it never makes it to your cells where its needed the most
The BDNF gene is also important in this process because it helps regulate neuron survival and new neural connections
Lets take a look at the use of GLP-1 weight loss drugs among athletes and why it may lead to dehydration
Al-Beltagi M, Saeed NK, Bediwy AS, Bediwy EA, Elbeltagi R (2024)
doi: 10.1038/ijo.2016.67 42 FujiokaKONeilPDaviesMGreenwayFLauDClaudiusBet al